Frank D. Heuszel, Chief Executive Officer at IMPACT BIOMEDICAL INC. (IBO), bought 500 shares at $2.26 ($1K) on 2024-12-05, disclosed to the SEC on 2024-12-09.
Open-market purchase of $1k IBO by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |